Age-Dependent TLR3 Expression of the Intestinal Epithelium Contributes to Rotavirus Susceptibility

Rotavirus is a major cause of diarrhea worldwide and exhibits a pronounced small intestinal epithelial cell (IEC) tropism. Both human infants and neonatal mice are highly susceptible, whereas adult individuals remain asymptomatic and shed only low numbers of viral particles. Here we investigated age-dependent mechanisms of the intestinal epithelial innate immune response to rotavirus infection in an oral mouse infection model. Expression of the innate immune receptor for viral dsRNA, Toll-like receptor (Tlr) 3 was low in the epithelium of suckling mice but strongly increased during the postnatal period inversely correlating with rotavirus susceptibility, viral shedding and histological damage. Adult mice deficient in Tlr3 (Tlr3^−/−) or the adaptor molecule Trif (Trif^Lps2/Lps2) exerted significantly higher viral shedding and decreased epithelial expression of proinflammatory and antiviral genes as compared to wild-type animals. In contrast, neonatal mice deficient in Tlr3 or Trif did not display impaired cell stimulation or enhanced rotavirus susceptibility. Using chimeric mice, a major contribution of the non-hematopoietic cell compartment in the Trif-mediated antiviral host response was detected in adult animals. Finally, a significant age-dependent increase of TLR3 expression was also detected in human small intestinal biopsies. Thus, upregulation of epithelial TLR3 expression during infancy might contribute to the age-dependent susceptibility to rotavirus infection.     

The p53-target gene puma drives neutrophil-mediated protection against lethal bacterial sepsis

Disruption of p53/Puma-mediated apoptosis protects against lethality due to DNA damage. Here we demonstrate the unexpected requirement of the pro-apoptotic p53-target gene Puma to mount a successful innate immune response to bacterial sepsis. Puma^−/− mice rapidly died when challenged with bacteria. While the immune response in Puma^−/− mice was unchanged in cell migration, phagocytosis and bacterial killing, sites of infection accumulated large abscesses and sepsis was progressive. Blocking p53/Puma-induced apoptosis during infection caused resistance to ROS-induced cell death in the CD49d+ neutrophil subpopulation, resulting in insufficient immune resolution. This study identifies a biological role for p53/Puma apoptosis in optimizing neutrophil lifespan so as to ensure the proper clearance of bacteria and exposes a counter-balance between the innate immune response to infection and survival from DNA damage.     

Fighting mycobacteria through ISGylation

The role of ISGylation in humans has been a long-standing question. A recent groundbreaking study by the Casanova group shows it is essential in the defence against mycobacterial disease but dispensable for other types of infection.Bogunovic et al. (2012). Science, Epub: Aug 2. DOI: 10.1126/science.1224026Our bodies use interferon (IFN) signalling as a central pathway to limit the spread of pathogens, such as viruses, bacteria and parasites. After pathogen exposure, IFN production leads to the activation of immune cells—such as natural killer cells, macrophages and T lymphocytes—which mediate pathogen clearance. There are two main types of IFN signalling, type I and II. In type I signalling, IFNs α and β—produced mainly by leukocytes and fibroblasts, respectively—stimulate macrophages and natural killer (NK) cells to initiate an antiviral response. In type II signalling, IFNγ from activated T cells and NK cells potentiate type I signalling and promote inflammation. During type I signalling IFNα and IFNβ bind to their cognate receptors, which results in the induction of IFN-stimulated genes (ISGs). A key function of ISGs is to interfere with viral replication, hence the name interferon. One of the most strongly induced ISGs is ISG15, a small protein consisting of two ubiquitin folds connected with a hinge spacer, thus resembling di-ubiquitin [1]. It has been proposed that ISGylation is antiviral in mice, but its effects on human virus infection or other functional roles have been a long-standing question in the field. A study by the Casanova group provides important new insights into the role of ISG15 in humans, showing it is essential in the defence against mycobacterial disease but dispensable for other types of infection [2].Similarly to ubiquitin, ISG15 can be conjugated to other proteins and several hundred targets have been suggested from proteomic studies [3]. However, few targets have been carefully evaluated, among them JAK1, STAT1, ERK1/2, PLCγ1, p63, PML-RARα, UBC13, filamin B and several viral proteins. In analogy to the ubiquitin system, ISG15 conjugation is mediated by an enzymatic cascade consisting of an E1 activating enzyme Ube1L, an E2 conjugating enzyme UbcH8 and a HECT-domain containing E3 ligase HERC5 (Fig 1A). Notably, both ISG15 and the E1/E2/E3 cascade are induced by type I IFN signalling.Open in a separate windowFigure 1ISGylation and its function in the antimycobacterial response. (A) The ISG15 conjugation system. ISG15 is activated by an E1 enzyme and conjugated to substrates (green) by the action of E2 and E3 enzymes. HERC5 (HERC6 in mice) is the main ISGylating E3. (B) Mycobacterial infection induces IFNα/β production, which stimulates ISG15 synthesis and secretion in granulocytes. Secreted ISG15 can then activate NK cells to produce IFNγ, which stimulates immune system cells. See text for details. (C) HERC5 has been described to bind to polysomes and to promote cotranslational ISGylation of newly synthesized proteins. EFP, oestrogen-responsive finger protein; HERC5/6, HECT and RLD domain containing E3 ubiquitin protein ligases 5/6; HHARI, human homologue of Drosophila ariadne; IFNα/β/γ;, interferon α/β/γ; IFNαR, interferon α receptor; IL-12, interleukin 12; ISG15, interferon-stimulated gene 15; Lys, lysine; mRNA, messenger RNA; NK, natural killer; TLR, Toll-like receptor; UbcH8, ubiquitin conjugating enzyme H8; Ube1L, ubiquitin activating enzyme E1-like.Knowledge of the biological functions of ISGylation comes mainly from the analysis of knockout mice for ISG15, Ube1L and from in vitro studies. ISG15^−/− mice are more prone to infection by certain viruses, such as Sindbis, influenza A/B and herpes simplex 1 [4]. Ube1L^−/− mice are also sensitized towards Sindbis and influenza infections [5]. Furthermore, ISG15 can inhibit the budding of certain viruses and modify viral proteins, and some viruses have developed strategies to inhibit ISGylation, underscoring the function of ISG15 and ISGylation in the antiviral response [6]. However, other viruses—such as vesicular stomatitis and lymphocytic choriomeningitis virus—have similar effects on ISG15^−/− and wild-type mice [7], suggesting specialized functions of ISGylation after viral infection. In addition, a closer look at the role of ISG15 in regulating human viruses complicates the picture further: ISG15 has been found to stimulate rather than inhibit hepatitis C virus production in vitro, probably by preventing the degradation of viral proteins through competition between ISGylation and ubiquitylation [8]. Considering the limited number of viral infections common to both mice and man, it has been difficult to extrapolate what the in vivo functions of ISGylation might be in humans.The Bogunovic et al [2] study is a clear step forward in our understanding of ISG15 function in infection biology. By analysing patients with the rare paediatric syndrome, Mendelian susceptibility to mycobacterial disease (MSMD), they identified mutations in ISG15 that lead to its loss of expression and suggest that these mutations cause the disease. Importantly, these patients do not suffer from increased sensitivity to viral infections but show severe clinical symptoms when exposed to weakly pathogenic mycobacteria, such as Mycobacterium bovis.As has been shown in ISG15^−/− and Ube1L^−/− mice, Bogunovic et al found that cells from MSMD patients lack ISG15 expression after IFNα/β stimulation, but other ISGs are induced normally, confirming that ISG15 is not essential to elicit an IFN response [2]. Furthermore, patient cell lines are not more susceptible to infection by viruses such as herpes simplex virus, Sindbis virus and vesicular stomatitis virus. Secretion of ISG15 by granulocytes from gelatinase and secretory granules is probably an important process in response to mycobacterial infection that cannot be triggered by, for example, bacterial lipopolysaccharides (Fig 1B). Monocytes and lymphocytes are known to secrete ISG15, and Casanova and colleagues show that even transfected HEK293T cells can do so—suggesting that ISG15 is both an intracellular and a secreted protein—independently of the cellular context. The main function of secreted ISG15 seems to be the triggering of IFNγ release, preferentially from NK cells, but also from T cells. Interestingly, IFNγ secretion is also stimulated by modified ISG15 that can no longer be conjugated to target proteins. This indicates that immune cells either have an ISG15 receptor or that secreted ISG15, which is endocytosed, can induce a response without being conjugated to an intracellular target. Importantly, ISG15 secretion is lost in cells from MSMD patients and, consistently, MSMD leukocytes stimulated with mycobacteria produce greatly reduced amounts of IFNγ, which can be restored by providing recombinant ISG15. In addition, the study also demonstrates that ISG15^−/− mice are more susceptible to mycobacterial infection than their wild-type littermates.Thus, the Bogunovic study identifies a common function of ISG15 in vertebrates: the ability to counteract mycobacterial infections by activating NK cells. The data also suggest that some viruses and bacteria must share pathogen-associated molecular patterns that resemble those of mycobacteria, thus initiating a similar response that involves IFNα/β, which is required for ISG15 induction. The initial activation of this mechanism by mycobacteria remains to be identified and seems to be complex, as treatment of macrophages with IFNα/β during mycobacterial infection has been shown to induce the loss of their mycobacteriostatic properties [9]; partly at odds with the conclusions from this study. These discrepancies notwithstanding, the new insights reveal an essential function for ISG15 in antimycobacterial signalling. Mycobacterial infections are hard to fight and thus the finding that ISG15 is a major effector between granulocytes and NK cells might help develop new treatment strategies. Other cellular mediators, such as the macrophage–T-cell pathway, are a crucial host defence against pathogenic (M. tuberculosis) and nonpathogenic mycobacteria (M. bovis), as well as salmonella, in other variants of MSMD. Hence, Casanova and colleagues speculate that the granulocyte–NK-cell pathway, which involves ISG15 and IFNγ, might constitute a more innate complement to the macrophage–T-cell pathway, which requires IL-12/IFNγ. However, they also report a synergistic effect of a combined treatment of cells with ISG15 and IL-12, which rather argues that the granulocyte–NK-cell and the macrophage–T-cell systems act together. Furthermore, both granulocytes and macrophages express Toll-like receptors (TLRs) that recognize mycobacterial structures—such as TLR2 for the lipomannan of M. tuberculosis.Finally, whether covalent modification of target proteins within cells by ISG15 is important during infection remains unclear. It is difficult to speculate what the main effects would be, as ISG15 modifies targets in diverse cellular pathways. Notably, the E3 ligase for ISG15 conjugation HERC5 has been shown to be associated physically with polysomes, leading to cotranslational ISGylation of newly synthesized proteins, which probably inhibits protein function in general (Fig 1C; [10]). Thus, ISG15 might have two roles in preparing cells to fight pathogens: intracellular proteome remodelling and initiating antimicrobial signalling pathways. It will be interesting to see if and how these functions intersect.     

ISG15 Arg151 and the ISG15-Conjugating Enzyme UbE1L Are Important for Innate Immune Control of Sindbis Virus

Interferon (IFN)-stimulated gene 15 (ISG15) is a ubiquitin-like molecule that conjugates to target proteins via a C-terminal LRLRGG motif and has antiviral function in vivo. We used structural modeling to predict human ISG15 (hISG15) residues important for interacting with its E1 enzyme, UbE1L. Kinetic analysis revealed that mutation of arginine 153 to alanine (R153A) ablated hISG15-hUbE1L binding and transthiolation of UbcH8. Mutation of other predicted UbE1L-interacting residues had minimal effects on the transfer of ISG15 from UbE1L to UbcH8. The capacity of hISG15 R153A to form protein conjugates in 293T cells was markedly diminished. Mutation of the homologous residue in mouse ISG15 (mISG15), arginine 151, to alanine (R151A) also attenuated protein ISGylation following transfection into 293T cells. We assessed the role of ISG15-UbE1L interactions in control of virus infection by constructing double subgenomic Sindbis viruses that expressed the mISG15 R151A mutant. While expression of mISG15 protected alpha/beta-IFN-receptor-deficient (IFN-αβR^−/−) mice from lethality following Sindbis virus infection, expression of mISG15 R151A conferred no survival benefit. The R151A mutation also attenuated ISG15's ability to decrease Sindbis virus replication in IFN-αβR^−/− mice or prolong survival of ISG15^−/− mice. The importance of UbE1L was confirmed by demonstrating that mice lacking this ISG15 E1 enzyme were highly susceptible to Sindbis virus infection. Together, these data support a role for protein conjugation in the antiviral effects of ISG15.     

ISG15 Regulates Peritoneal Macrophages Functionality against Viral Infection

Upon viral infection, the production of type I interferon (IFN) and the subsequent upregulation of IFN stimulated genes (ISGs) generate an antiviral state with an important role in the activation of innate and adaptive host immune responses. The ubiquitin-like protein (UBL) ISG15 is a critical IFN-induced antiviral molecule that protects against several viral infections, but the mechanism by which ISG15 exerts its antiviral function is not completely understood. Here, we report that ISG15 plays an important role in the regulation of macrophage responses. ISG15−/− macrophages display reduced activation, phagocytic capacity and programmed cell death activation in response to vaccinia virus (VACV) infection. Moreover, peritoneal macrophages from mice lacking ISG15 are neither able to phagocyte infected cells nor to block viral infection in co-culture experiments with VACV-infected murine embryonic fibroblast (MEFs). This phenotype is independent of cytokine production and secretion, but clearly correlates with impaired activation of the protein kinase AKT in ISG15 knock-out (KO) macrophages. Altogether, these results indicate an essential role of ISG15 in the cellular immune antiviral response and point out that a better understanding of the antiviral responses triggered by ISG15 may lead to the development of therapies against important human pathogens.     

Mice Lacking the ISG15 E1 Enzyme UbE1L Demonstrate Increased Susceptibility to both Mouse-Adapted and Non-Mouse-Adapted Influenza B Virus Infection

ISG15 functions as a critical antiviral molecule against influenza virus, with infection inducing both the conjugation of ISG15 to target proteins and production of free ISG15. Here, we report that mice lacking the ISG15 E1 enzyme UbE1L fail to form ISG15 conjugates. Both UbE1L^−/− and ISG15^−/− mice display increased susceptibility to influenza B virus infection, including non-mouse-adapted strains. Finally, we demonstrate that ISG15 controls influenza B virus infection through its action within radioresistant stromal cells and not bone marrow-derived cells. Thus, the conjugation of ISG15 to target proteins within stromal cells is critical to its activity against influenza virus.     

Interferon-Induced Ifit2/ISG54 Protects Mice from Lethal VSV Neuropathogenesis

Interferon protects mice from vesicular stomatitis virus (VSV) infection and pathogenesis; however, it is not known which of the numerous interferon-stimulated genes (ISG) mediate the antiviral effect. A prominent family of ISGs is the interferon-induced with tetratricopeptide repeats (Ifit) genes comprising three members in mice, Ifit1/ISG56, Ifit2/ISG54 and Ifit3/ISG49. Intranasal infection with a low dose of VSV is not lethal to wild-type mice and all three Ifit genes are induced in the central nervous system of the infected mice. We tested their potential contributions to the observed protection of wild-type mice from VSV pathogenesis, by taking advantage of the newly generated knockout mice lacking either Ifit2 or Ifit1. We observed that in Ifit2 knockout (Ifit2 ^−/−) mice, intranasal VSV infection was uniformly lethal and death was preceded by neurological signs, such as ataxia and hind limb paralysis. In contrast, wild-type and Ifit1 ^−/− mice were highly protected and survived without developing such disease. However, when VSV was injected intracranially, virus replication and survival were not significantly different between wild-type and Ifit2^−/− mice. When administered intranasally, VSV entered the central nervous system through the olfactory bulbs, where it replicated equivalently in wild-type and Ifit2 ^−/− mice and induced interferon-β. However, as the infection spread to other regions of the brain, VSV titers rose several hundred folds higher in Ifit2 ^−/− mice as compared to wild-type mice. This was not caused by a broadened cell tropism in the brains of Ifit2 ^−/− mice, where VSV still replicated selectively in neurons. Surprisingly, this advantage for VSV replication in the brains of Ifit2^−/− mice was not observed in other organs, such as lung and liver. Pathogenesis by another neurotropic RNA virus, encephalomyocarditis virus, was not enhanced in the brains of Ifit2 ^−/− mice. Our study provides a clear demonstration of tissue-, virus- and ISG-specific antiviral action of interferon.     

2��-O Methylation of the Viral mRNA Cap by West Nile Virus Evades Ifit1-Dependent and -Independent Mechanisms of Host Restriction In Vivo

Prior studies have shown that 2′-O methyltransferase activity of flaviviruses, coronaviruses, and poxviruses promotes viral evasion of Ifit1, an interferon-stimulated innate immune effector protein. Viruses lacking 2′-O methyltransferase activity exhibited attenuation in primary macrophages that was rescued in cells lacking Ifit1 gene expression. Here, we examined the role of Ifit1 in restricting pathogenesis in vivo of wild type WNV (WNV-WT) and a mutant in the NS5 gene (WNV-E218A) lacking 2′-O methylation of the 5′ viral RNA cap. While deletion of Ifit1 had marginal effects on WNV-WT pathogenesis, WNV-E218A showed increased replication in peripheral tissues of Ifit1 ^−/− mice after subcutaneous infection, yet this failed to correlate with enhanced infection in the brain or lethality. In comparison, WNV-E218A was virulent after intracranial infection as judged by increased infection in different regions of the central nervous system (CNS) and a greater than 16,000-fold decrease in LD₅₀ values in Ifit1 ^−/− compared to wild type mice. Ex vivo infection experiments revealed cell-type specific differences in the ability of an Ifit1 deficiency to complement the replication defect of WNV-E218A. In particular, WNV-E218A infection was impaired in both wild type and Ifit1 ^−/− brain microvascular endothelial cells, which are believed to participate in blood-brain barrier (BBB) regulation of virus entry into the CNS. A deficiency of Ifit1 also was associated with increased neuronal death in vivo, which was both cell-intrinsic and mediated by immunopathogenic CD8⁺ T cells. Our results suggest that virulent strains of WNV have largely evaded the antiviral effects of Ifit1, and viral mutants lacking 2′-O methylation are controlled in vivo by Ifit1-dependent and -independent mechanisms in different cell types.     

Chronic Joint Disease Caused by Persistent Chikungunya Virus Infection Is Controlled by the Adaptive Immune Response

Chikungunya virus (CHIKV) is a reemerging mosquito-borne pathogen that causes incapacitating disease in humans characterized by intense joint pain that can persist for weeks, months, or even years. Although there is some evidence of persistent CHIKV infection in humans suffering from chronic rheumatologic disease symptoms, little is known about chronic disease pathogenesis, and no specific therapies exist for acute or chronic CHIKV disease. To investigate mechanisms of chronic CHIKV-induced disease, we utilized a mouse model and defined the duration of CHIKV infection in tissues and the associated histopathological changes. Although CHIKV RNA was readily detectable in a variety of tissues very early after infection, CHIKV RNA persisted specifically in joint-associated tissues for at least 16 weeks. Inoculation of Rag1^−/− mice, which lack T and B cells, resulted in higher viral levels in a variety of tissues, suggesting that adaptive immunity controls the tissue specificity and persistence of CHIKV infection. The presence of CHIKV RNA in tissues of wild-type and Rag1^−/− mice was associated with histopathological evidence of synovitis, arthritis, and tendonitis; thus, CHIKV-induced persistent arthritis is not mediated primarily by adaptive immune responses. Finally, we show that prophylactic administration of CHIKV-specific monoclonal antibodies prevented the establishment of CHIKV persistence, whereas therapeutic administration had tissue-specific efficacy. These findings suggest that chronic musculoskeletal tissue pathology is caused by persistent CHIKV infection and controlled by adaptive immune responses. Our results have significant implications for the development of strategies to mitigate the disease burden associated with CHIKV infection in humans.     

Development of a Highly Protective Combination Monoclonal Antibody Therapy against Chikungunya Virus

Chikungunya virus (CHIKV) is a mosquito-transmitted alphavirus that causes global epidemics of a debilitating polyarthritis in humans. As there is a pressing need for the development of therapeutic agents, we screened 230 new mouse anti-CHIKV monoclonal antibodies (MAbs) for their ability to inhibit infection of all three CHIKV genotypes. Four of 36 neutralizing MAbs (CHK-102, CHK-152, CHK-166, and CHK-263) provided complete protection against lethality as prophylaxis in highly susceptible immunocompromised mice lacking the type I IFN receptor (Ifnar^−/−) and mapped to distinct epitopes on the E1 and E2 structural proteins. CHK-152, the most protective MAb, was humanized, shown to block viral fusion, and require Fc effector function for optimal activity in vivo. In post-exposure therapeutic trials, administration of a single dose of a combination of two neutralizing MAbs (CHK-102+CHK-152 or CHK-166+CHK-152) limited the development of resistance and protected immunocompromised mice against disease when given 24 to 36 hours before CHIKV-induced death. Selected pairs of highly neutralizing MAbs may be a promising treatment option for CHIKV in humans.     

Characterization of NLRP12 during the In Vivo Host Immune Response to Klebsiella pneumoniae and Mycobacterium tuberculosis

The majority of nucleotide binding domain leucine rich repeats-containing (NLR) family members has yet to be functionally characterized. Of the described NLRs, most are considered to be proinflammatory and facilitate IL-1β production. However, a newly defined sub-group of NLRs that function as negative regulators of inflammation have been identified based on their abilities to attenuate NF-κB signaling. NLRP12 (Monarch-1) is a prototypical member of this sub-group that negatively regulates both canonical and noncanonical NF-κB signaling in biochemical assays and in colitis and colon cancer models. The role of NLRP12 in infectious diseases has not been extensively studied. Here, we characterized the innate immune response of Nlrp12^−/− mice following airway exposure to LPS, Klebsiella pneumoniae and Mycobacterium tuberculosis. In response to E. coli LPS, Nlrp12^−/− mice showed a slight decrease in IL-1β and increase in IL-6 production, but these levels were not statistically significant. During K. pneumoniae infection, we observed subtle differences in cytokine levels and significantly reduced numbers of monocytes and lymphocytes in Nlrp12^−/− mice. However, the physiological relevance of these findings is unclear as no overt differences in the development of lung disease were observed in the Nlrp12^−/− mice. Likewise, Nlrp12^−/− mice demonstrated pathologies similar to those observed in the wild type mice following M. tuberculosis infection. Together, these data suggest that NLRP12 does not significantly contribute to the in vivo host innate immune response to LPS stimulation, Klebsiella pneumonia infection or Mycobacterium tuberculosis.     

Kinetics of Transmission, Infectivity, and Genome Stability of Two Novel Mouse Norovirus Isolates in Breeding Mice

Murine noroviruses are a recently discovered group of viruses found within mouse research colonies in many animal facilities worldwide. In this study, we used 2 novel mouse norovirus (MNV) wildtype isolates to examine the kinetics of transmission and tissue distribution in breeding units of NOD.CB17-Prkdc^scid/J and backcrossed NOD.CB17-Prkdc^scid/J × NOD/ShiLtJ (N1) mice. Viral shedding in feces and dissemination to tissues of infected offspring mice were monitored by RT-PCR over a 6-wk period postpartum. Histologic sections of tissues from mice exposed to MNV were examined for lesions and their sera monitored for the presence of antibodies to MNV. Viruses shed in feces of parental and offspring mice were compared for sequence homology of the Orf2 gene. Studies showed that the wildtype viruses MNV5 and MNV6 behaved differently in terms of the kinetics of transmission and distribution to tissues of offspring mice. For MNV5, virus transmission from parents to offspring was not seen before 3 wk after birth, and neither isolate was transmitted between cages of infected and control mice. Susceptibility to infection was statistically different between the 2 mouse strains used in the study. Both immunodeficient NOD.CB17-Prkdc^scid/J mice and NOD.CB17-Prkdc^scid/J × NOD/ShiLtJ offspring capable of mounting an immune response shed virus in their feces throughout the 6-wk study period, but no gross or histologic lesions were present in infected tissues. Progeny viruses isolated from the feces of infected offspring showed numerous mutations in the Orf2 gene for MNV5 but not MNV6. These results confirm previous studies demonstrating that the biology of MNV in mice varies substantially with each virus isolate and mouse strain infected.Abbreviations: MNV, murine norovirus; MLN, mesenteric lymph nodes; NOD-scid, NOD.CB17-Prkdc^scid/J; VP1, viral protein 1The recent discovery of murine-specific noroviruses¹⁵ has stimulated concern in the laboratory animal health community regarding the potential for this group of viruses to cause disease in breeding colonies of mice or to negatively impact research with mice from norovirus infected colonies. Current knowledge of the biology of noroviruses in mice (MNV) is constrained by the limited number of virus isolates and mouse strains studied. One study¹⁵described the biologic and physicochemical properties of the original MNV1 isolated from mice deficient in a specific innate immune function. More recently, this innate immune deficiency has been mapped to STAT1 regulation of IFNαβ secretion.²¹Previous work¹⁵ demonstrated that inoculation of MNV1 into mouse strains deficient in the acquired immune response (129 RAG 2^−/−, B6 RAG1^−/−) resulted in the development of persistent infections with no evidence of disease, whereas inoculation of fully immunocompetent mice (129S6/SvEvTac) resulted in rapid elimination of MNV1, with viral RNA undetectable in the viscera by 3 d after inoculation. More recently, infections of outbred immunocompetent mouse strains with 3 wildtype isolates of MNV obtained from different geographic areas of the United States have been described.¹¹ Virus was detected in the feces and tissue of infected mice throughout the 8-wk study, suggesting that some isolates of MNV may persistently infect immunocompetent mice.The purpose of the present investigation was to extend the current knowledge of MNV by using 2 isolates of the virus in mouse strains that have not been previously used as infection models for MNV. We examined natural virus transmission from infected breeders to offspring, kinetics of infection within litters of infected breeding mice, and the pathogenesis of infection in breeding colonies of mice. In addition, we examined the effect of virus passage from parents to offspring on genomic stability of these 2 viral isolates. Exposure of offspring of immunodeficient mice and immunocompetent mice to the 2 different isolates of MNV resulted in different patterns of virus transmission, susceptibility to infection and kinetics of infection as shown by the progressive spread of virus within litters and in intestinal and extraintestinal tissues. MNV was shed persistently in the feces of all mice tested regardless of immune status, and viral progeny isolated from offspring mice contained genome sequence differences from the parent virus in the Orf2 gene, an area of the MNV genome known to be susceptible to mutations.     

Enhanced antibacterial potential in UBP43-deficient mice against Salmonella typhimurium infection by up-regulating type I IFN signaling

ISG15 is an IFN-inducible ubiquitin-like protein and its expression and conjugation to target proteins are dramatically induced upon viral or bacterial infection. We have generated a UBP43 knockout mouse model that is lacking an ISG15-specific isopeptidase to study the biological role of the protein ISGylation system. We report that UBP43-deficient mice are hypersensitive to LPS-induced lethality and that TIR domain-containing adapter inducing IFN-beta --> IFN regulatory factor 3 --> type I IFN is the major axis to induce protein ISGylation and UBP43 expression in macrophages upon LPS treatment. In ubp43(-/-) macrophages, upon LPS treatment we detected increased expression of IFN-stimulated genes, including genes for several cytokines and chemokines involved in the innate immune response. The ubp43(-/-) mice were able to restrict the growth of Salmonella typhimurium more efficiently than wild-type mice. These results clearly demonstrate two aspects of IFN-signaling, a beneficial effect against pathogens but a detriment to the body without strict control.     

Infectious Chikungunya Virus in the Saliva of Mice,Monkeys and Humans

Chikungunya virus (CHIKV) is a reemerging, ordinarily mosquito-transmitted, alphavirus that occasionally produces hemorrhagic manifestations, such as nose bleed and bleeding gums, in human patients. Interferon response factor 3 and 7 deficient (IRF3/7^-/-) mice, which are deficient for interferon α/β responses, reliably develop hemorrhagic manifestations after CHIKV infection. Here we show that infectious virus was present in the oral cavity of CHIKV infected IRF3/7^-/- mice, likely due to hemorrhagic lesions in the olfactory epithelium that allow egress of infected blood into the nasal, and subsequently, oral cavities. In addition, IRF3/7^-/- mice were more susceptible to infection with CHIKV via intranasal and oral routes, with IRF3/7^-/- mice also able to transmit virus mouse-to-mouse without an arthropod vector. Cynomolgus macaques often show bleeding gums after CHIKV infection, and analysis of saliva from several infected monkeys also revealed the presence of viral RNA and infectious virus. Furthermore, saliva samples collected from several acute CHIKV patients with hemorrhagic manifestations were found to contain viral RNA and infectious virus. Oral fluids can therefore be infectious during acute CHIKV infections, likely due to hemorrhagic manifestations in the oral/nasal cavities.     

IPS-1 Is Essential for the Control of West Nile Virus Infection and Immunity

The innate immune response is essential for controlling West Nile virus (WNV) infection but how this response is propagated and regulates adaptive immunity in vivo are not defined. Herein, we show that IPS-1, the central adaptor protein to RIG-I-like receptor (RLR) signaling, is essential for triggering of innate immunity and for effective development and regulation of adaptive immunity against pathogenic WNV. IPS-1^−/− mice exhibited increased susceptibility to WNV infection marked by enhanced viral replication and dissemination with early viral entry into the CNS. Infection of cultured bone-marrow (BM) derived dendritic cells (DCs), macrophages (Macs), and primary cortical neurons showed that the IPS-1-dependent RLR signaling was essential for triggering IFN defenses and controlling virus replication in these key target cells of infection. Intriguingly, infected IPS-1^−/− mice displayed uncontrolled inflammation that included elevated systemic type I IFN, proinflammatory cytokine and chemokine responses, increased numbers of inflammatory DCs, enhanced humoral responses marked by complete loss of virus neutralization activity, and increased numbers of virus-specific CD8+ T cells and non-specific immune cell proliferation in the periphery and in the CNS. This uncontrolled inflammatory response was associated with a lack of regulatory T cell expansion that normally occurs during acute WNV infection. Thus, the enhanced inflammatory response in the absence of IPS-1 was coupled with a failure to protect against WNV infection. Our data define an innate/adaptive immune interface mediated through IPS-1-dependent RLR signaling that regulates the quantity, quality, and balance of the immune response to WNV infection.